Artificial intelligence is transforming medical diagnostics, with the AI imaging market set to grow from $1.9B in 2024 to $46.6B by 2034, driven by global partnerships.
 |
| From Istanbul to Silicon Valley, AI in healthcare is revolutionizing diagnostics and workflows. Market to hit $46.6B by 2034 as Türkiye becomes a key player. Image: CH |
Istanbul, Turkiye — July 3, 2025:
Artificial intelligence is rapidly transforming the global healthcare industry, particularly in diagnostic imaging, where the market is projected to soar from $1.9 billion in 2024 to $46.6 billion by 2034, growing at a 33.7% annual rate, according to new research, reads a DS post.
AI-powered platforms now account for 60% of all medical imaging revenues, driven by software solutions, cloud integration, and real-time diagnostic support. This segment is expanding at an unprecedented 43% annual rate, making it the fastest-growing area in healthcare AI.
While machine learning is currently the most widely adopted technology — used by 48% of healthcare organizations — computer vision, NLP, cloud systems, and 3D/4D imaging are gaining momentum.
Major global players are advancing through partnerships and acquisitions. Siemens Healthineers, for instance, has partnered with Google Cloud to bolster its AI and cloud infrastructure. The company also acquired Advanced Accelerator Applications (AAA) and Dotmatics, deepening its reach in nuclear medicine and life sciences software.
“AI is not just a technical tool — it’s the glue that binds healthcare technologies together,” said Amira Romani, senior vice president of innovation at Siemens Healthineers. “Our collaborations with over 100 startups worldwide focus on integrating their innovations into real clinical outcomes. The end goal is improving patient health.”
Romani emphasized that Türkiye is playing an increasingly strategic role. Siemens Healthineers recently opened an innovation center in Istanbul, aiming to scale local innovations for global deployment. “The Turkish ecosystem’s energy and problem-solving mindset make it ideal for high-impact collaboration,” she said.
Backed by venture capital, Türkiye’s AI startup ecosystem has grown 17-fold in just eight years, with 411 active companies as of mid-2025. Generative AI leads the momentum, with local startups targeting content creation, diagnostics, and intelligent assistants.
According to the Türkiye Artificial Intelligence Initiative (TRAI), this growth reflects both technological maturity and global potential. “Each new startup adds specialized value to our AI ecosystem,” said TRAI General Manager Can Sinemli. “We’re witnessing a qualitative leap in capability and innovation.”
Investors are taking note. TT Ventures, the investment arm of Türk Telekom, is actively backing health-focused startups such as Virasoft, Albert Health, Aivisiontech, and Hevi AI — all of which are developing tools for early diagnosis, chronic disease management, and preventative healthcare.
Meanwhile, Türkiye’s 212 NexT fund has extended its influence abroad, participating in a €15 million Series A round for French textile tech startup EverDye, which develops eco-friendly, low-energy dyeing solutions. EverDye’s innovation reduces environmental impact by cutting dyeing time by two-thirds using bio-based pigments.
At a recent enterprise summit hosted by OdineLabs, executives from PwC, Nvidia, Red Hat, and Georgia Tech discussed the strategic shift AI is driving across industries. Odine Chair Alper Tunga Burak said, “AI is no longer a theoretical tool — it is redefining how businesses operate, communicate, and compete.”
From Istanbul to Silicon Valley, the AI-driven reinvention of healthcare is moving fast. With diagnostics at the helm, global partnerships, startup agility, and scalable technologies are steering the industry toward a more personalized, preventive, and connected future.